175 related articles for article (PubMed ID: 30783863)
1. The clinical significance of a pathologically positive lymph node at the circumferential resection margin in rectal cancer.
Patel A; Green N; Sarmah P; Langman G; Chandrakumaran K; Youssef H
Tech Coloproctol; 2019 Feb; 23(2):151-159. PubMed ID: 30783863
[TBL] [Abstract][Full Text] [Related]
2. Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective study.
Suárez J; Goicoetxea A; Gómez ML; Jiménez G; Llanos MC; Jiménez J; Montes B; de Miguel M
J Surg Oncol; 2018 Dec; 118(7):1122-1128. PubMed ID: 30261110
[TBL] [Abstract][Full Text] [Related]
3. Circumferential margin involvement after total mesorectal excision for mid or low rectal cancer: are all R1 resections equal?
Beaufrère A; Guedj N; Maggiori L; Patroni A; Bedossa P; Panis Y
Colorectal Dis; 2017 Nov; 19(11):O377-O385. PubMed ID: 28941054
[TBL] [Abstract][Full Text] [Related]
4. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
5. Positive Circumferential Resection Margin in Rectal Cancer Is a Robust Predictor of Poor Long-term Prognosis With Clinicopathological Bias Between Groups Compensated by Propensity-score Matching Analysis.
Sugimoto K; Takahashi H; Yuki ; Irie T; Kawaguchi M; Kobari A; Amemiya K; Tsuchiya Y; Motegi S; Tsukamoto R; Honjo K; Okazawa YU; Kawai M; Ishiyama S; Takahashi M; Hoffman RM; Sakamoto K
Anticancer Res; 2023 Aug; 43(8):3623-3630. PubMed ID: 37500146
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
[TBL] [Abstract][Full Text] [Related]
7. Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.
Frambach P; Pucciarelli S; Perin A; Zuin M; Toppan P; Maretto I; Urso EDL; Spolverato G
Colorectal Dis; 2018 Dec; 20(12):O326-O334. PubMed ID: 30230157
[TBL] [Abstract][Full Text] [Related]
8. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
Zeng WG; Liu MJ; Zhou ZX; Wang ZJ
Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082
[TBL] [Abstract][Full Text] [Related]
9. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis.
Kim Y; Kim DY; Kim TH; Kim SY; Baek JY; Kim MJ; Chang HJ; Cha Y; Park SC; Oh JH
Br J Radiol; 2018 Dec; 91(1092):20180143. PubMed ID: 30129789
[TBL] [Abstract][Full Text] [Related]
10. Preoperative computed tomography assessment of circumferential resection margin in retroperitonealized colon cancer predicts disease-free survival.
Seo N; Lim JS; Chung T; Lee JM; Min BS; Kim MJ
Eur Radiol; 2023 Apr; 33(4):2757-2767. PubMed ID: 36355197
[TBL] [Abstract][Full Text] [Related]
11. Management of the positive pathologic circumferential resection margin in rectal cancer: A national cancer database (NCDB) study.
Reif de Paula T; Augestad KM; Kiran RP; Keller DS
Eur J Surg Oncol; 2021 Feb; 47(2):296-303. PubMed ID: 32800594
[TBL] [Abstract][Full Text] [Related]
12. Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population-based retrospective study.
Liu Q; Luo D; Cai S; Li Q; Li X
Cancer Med; 2018 Aug; 7(8):3673-3681. PubMed ID: 29992773
[TBL] [Abstract][Full Text] [Related]
13. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Oncologic Outcomes of Minimally Invasive Proctectomy for Rectal Adenocarcinoma.
Merchea A; Ali SM; Kelley SR; Duchalais E; Alabbad JY; Dozois EJ; Larson DW
J Gastrointest Surg; 2018 Aug; 22(8):1412-1417. PubMed ID: 29594912
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors Associated With Circumferential Resection Margin Positivity in Rectal Cancer: A Binational Registry Study.
Warrier SK; Kong JC; Guerra GR; Chittleborough TJ; Naik A; Ramsay RG; Lynch AC; Heriot AG
Dis Colon Rectum; 2018 Apr; 61(4):433-440. PubMed ID: 29521824
[TBL] [Abstract][Full Text] [Related]
17. Using a Lymph Node Count Metric to Identify Underperforming Hospitals After Rectal Cancer Surgery.
Raoof M; Zafar SN; Ituarte PHG; Krouse RS; Melstrom K
J Surg Res; 2019 Apr; 236():216-223. PubMed ID: 30694758
[TBL] [Abstract][Full Text] [Related]
18. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
19. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y
Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
